183 related articles for article (PubMed ID: 15618202)
41. Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits.
García A; Marini RP; Catalfamo JL; Knox KA; Schauer DB; Rogers AB; Fox JG
Microbes Infect; 2008 May; 10(6):650-6. PubMed ID: 18462972
[TBL] [Abstract][Full Text] [Related]
42. PCR detection of enterohemorrhagic Escherichia coli O145 in food by targeting genes in the E. coli O145 O-antigen gene cluster and the shiga toxin 1 and shiga toxin 2 genes.
Fratamico PM; DebRoy C; Miyamoto T; Liu Y
Foodborne Pathog Dis; 2009 Jun; 6(5):605-11. PubMed ID: 19435408
[TBL] [Abstract][Full Text] [Related]
43. A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.
Shelton DR; Karns JS; Park CH
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):7-10. PubMed ID: 18550318
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms.
Hagel C; Krasemann S; Löffler J; Püschel K; Magnus T; Glatzel M
Brain Pathol; 2015 Mar; 25(2):146-56. PubMed ID: 24989888
[TBL] [Abstract][Full Text] [Related]
45. Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2.
Wilson C; Foster GH; Bitzan M
Infection; 2005 Oct; 33(5-6):362-7. PubMed ID: 16258868
[TBL] [Abstract][Full Text] [Related]
46. Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.
Mühlen S; Ramming I; Pils MC; Koeppel M; Glaser J; Leong J; Flieger A; Stecher B; Dersch P
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015030
[TBL] [Abstract][Full Text] [Related]
47. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
[TBL] [Abstract][Full Text] [Related]
48. Haemolytic uraemic syndrome, verotoxigenic Escherichia coli and food safety.
Salmon RL; Parry SM
J Nephrol; 1997; 10(6):279-82. PubMed ID: 9442440
[No Abstract] [Full Text] [Related]
49. Platelet thrombus formation in eHUS is prevented by anti-MBL2.
Kushak RI; Boyle DC; Rosales IA; Ingelfinger JR; Stahl GL; Ozaki M; Colvin RB; Grabowski EF
PLoS One; 2019; 14(12):e0220483. PubMed ID: 31881024
[TBL] [Abstract][Full Text] [Related]
50. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
[TBL] [Abstract][Full Text] [Related]
51. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
[TBL] [Abstract][Full Text] [Related]
52. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
53. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.
Goldwater PN
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):653-63. PubMed ID: 17678428
[TBL] [Abstract][Full Text] [Related]
54. Hemolytic uremic syndrome: an emerging health risk.
Razzaq S
Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
[TBL] [Abstract][Full Text] [Related]
55. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets.
Tzipori S; Chow CW; Powell HR
J Clin Pathol; 1988 Oct; 41(10):1099-103. PubMed ID: 3056980
[TBL] [Abstract][Full Text] [Related]
56. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
Johnson KE; Thorpe CM; Sears CL
Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
[TBL] [Abstract][Full Text] [Related]
57. O148 Shiga toxin-producing Escherichia coli outbreak: microbiological investigation as a useful complement to epidemiological investigation.
Espié E; Grimont F; Vaillant V; Montet MP; Carle I; Bavai C; de Valk H; Vernozy-Rozand C
Clin Microbiol Infect; 2006 Oct; 12(10):992-8. PubMed ID: 16961636
[TBL] [Abstract][Full Text] [Related]
58. Genetic profiles of Shiga toxin and intimin genes found in stool broth cultures: a 2-year reference laboratory study.
Michel PA; Kase JA
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):85-92. PubMed ID: 19748416
[TBL] [Abstract][Full Text] [Related]
59. CCR2-dependent Gr1
Pohl JM; Volke JK; Thiebes S; Brenzel A; Fuchs K; Beziere N; Ehrlichmann W; Pichler BJ; Squire A; Gueler F; Engel DR
Eur J Immunol; 2018 Jun; 48(6):990-1000. PubMed ID: 29446073
[TBL] [Abstract][Full Text] [Related]
60. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
